Logo image of ALL

ALLSTATE CORP (ALL) Stock Fundamental Analysis

NYSE:ALL - New York Stock Exchange, Inc. - US0200021014 - Common Stock - Currency: USD

190.71  +4.64 (+2.49%)

Fundamental Rating

5

ALL gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 144 industry peers in the Insurance industry. The financial health of ALL is average, but there are quite some concerns on its profitability. ALL is valued quite cheap, while showing a decent growth score. This is a good combination! Finally ALL also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year ALL was profitable.
ALL had a positive operating cash flow in the past year.
In multiple years ALL reported negative net income over the last 5 years.
ALL had a positive operating cash flow in each of the past 5 years.
ALL Yearly Net Income VS EBIT VS OCF VS FCFALL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B

1.2 Ratios

Looking at the Return On Assets, with a value of 3.61%, ALL is in the better half of the industry, outperforming 66.20% of the companies in the same industry.
ALL's Return On Equity of 19.69% is amongst the best of the industry. ALL outperforms 81.69% of its industry peers.
Industry RankSector Rank
ROA 3.61%
ROE 19.69%
ROIC N/A
ROA(3y)-0.09%
ROA(5y)1.6%
ROE(3y)-1.33%
ROE(5y)6.42%
ROIC(3y)N/A
ROIC(5y)N/A
ALL Yearly ROA, ROE, ROICALL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 15

1.3 Margins

ALL has a Profit Margin (6.58%) which is comparable to the rest of the industry.
ALL has a Operating Margin (9.01%) which is in line with its industry peers.
In the last couple of years the Operating Margin of ALL has declined.
Industry RankSector Rank
OM 9.01%
PM (TTM) 6.58%
GM N/A
OM growth 3Y-73.97%
OM growth 5Y-45.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALL Yearly Profit, Operating, Gross MarginsALL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15

More info and screens

4

2. Health

2.1 Basic Checks

ALL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALL has less shares outstanding
ALL has less shares outstanding than it did 5 years ago.
ALL has a better debt/assets ratio than last year.
ALL Yearly Shares OutstandingALL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M
ALL Yearly Total Debt VS Total AssetsALL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20B 40B 60B 80B 100B

2.2 Solvency

ALL has a debt to FCF ratio of 0.98. This is a very positive value and a sign of high solvency as it would only need 0.98 years to pay back of all of its debts.
The Debt to FCF ratio of ALL (0.98) is better than 67.61% of its industry peers.
ALL has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
ALL has a Debt to Equity ratio (0.39) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 0.98
Altman-Z N/A
ROIC/WACCN/A
WACC8.47%
ALL Yearly LT Debt VS Equity VS FCFALL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ALL Yearly Current Assets VS Current LiabilitesALL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 362.68% over the past year.
ALL shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -35.31% yearly.
ALL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.67%.
The Revenue has been growing slightly by 7.47% on average over the past years.
EPS 1Y (TTM)362.68%
EPS 3Y-60.54%
EPS 5Y-35.31%
EPS Q2Q%382.72%
Revenue 1Y (TTM)11.67%
Revenue growth 3Y10.86%
Revenue growth 5Y7.47%
Sales Q2Q%10.55%

3.2 Future

ALL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 94.56% yearly.
ALL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.99% yearly.
EPS Next Y1713.23%
EPS Next 2Y359.52%
EPS Next 3Y185.3%
EPS Next 5Y94.56%
Revenue Next Year9.74%
Revenue Next 2Y8.62%
Revenue Next 3Y8.51%
Revenue Next 5Y5.99%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ALL Yearly Revenue VS EstimatesALL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20B 40B 60B
ALL Yearly EPS VS EstimatesALL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15 20

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.58, which indicates a very decent valuation of ALL.
Compared to the rest of the industry, the Price/Earnings ratio of ALL is on the same level as its industry peers.
When comparing the Price/Earnings ratio of ALL to the average of the S&P500 Index (28.58), we can say ALL is valued rather cheaply.
ALL is valuated reasonably with a Price/Forward Earnings ratio of 9.93.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALL indicates a somewhat cheap valuation: ALL is cheaper than 61.27% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ALL to the average of the S&P500 Index (24.47), we can say ALL is valued rather cheaply.
Industry RankSector Rank
PE 11.58
Fwd PE 9.93
ALL Price Earnings VS Forward Price EarningsALL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ALL's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ALL is cheaper than 61.97% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ALL is valued a bit cheaper than 64.79% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.14
EV/EBITDA 9.13
ALL Per share dataALL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

ALL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALL's earnings are expected to grow with 185.30% in the coming years.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y359.52%
EPS Next 3Y185.3%

More info and screens

7

5. Dividend

5.1 Amount

ALL has a Yearly Dividend Yield of 1.99%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.11, ALL has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.27, ALL has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.99%

5.2 History

On average, the dividend of ALL grows each year by 12.54%, which is quite nice.
ALL has been paying a dividend for at least 10 years, so it has a reliable track record.
ALL has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)12.54%
Div Incr Years14
Div Non Decr Years15
ALL Yearly Dividends per shareALL Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3

5.3 Sustainability

26.17% of the earnings are spent on dividend by ALL. This is a low number and sustainable payout ratio.
The dividend of ALL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP26.17%
EPS Next 2Y359.52%
EPS Next 3Y185.3%
ALL Yearly Income VS Free CF VS DividendALL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B
ALL Dividend Payout.ALL Dividend Payout, showing the Payout Ratio.ALL Dividend Payout.PayoutRetained Earnings

More info and screens

ALLSTATE CORP

NYSE:ALL (1/27/2025, 11:54:54 AM)

190.71

+4.64 (+2.49%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)10-30 2024-10-30/amc
Earnings (Next)02-05 2025-02-05/amc
Inst Owners80.17%
Inst Owner Change0.13%
Ins Owners0.53%
Ins Owner Change-2.16%
Market Cap50.50B
Analysts79.23
Price Target233.07 (22.21%)
Short Float %0.91%
Short Ratio1.44
Dividend
Industry RankSector Rank
Dividend Yield 1.99%
Yearly Dividend3.93
Dividend Growth(5Y)12.54%
DP26.17%
Div Incr Years14
Div Non Decr Years15
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)198.67%
Min EPS beat(2)64.3%
Max EPS beat(2)333.04%
EPS beat(4)4
Avg EPS beat(4)117.63%
Min EPS beat(4)28.89%
Max EPS beat(4)333.04%
EPS beat(8)7
Avg EPS beat(8)68.67%
EPS beat(12)8
Avg EPS beat(12)47.92%
EPS beat(16)11
Avg EPS beat(16)40.32%
Revenue beat(2)0
Avg Revenue beat(2)-1.29%
Min Revenue beat(2)-2.51%
Max Revenue beat(2)-0.07%
Revenue beat(4)1
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-3.3%
Max Revenue beat(4)1.38%
Revenue beat(8)2
Avg Revenue beat(8)1.6%
Revenue beat(12)6
Avg Revenue beat(12)6.49%
Revenue beat(16)10
Avg Revenue beat(16)10.55%
PT rev (1m)3.17%
PT rev (3m)10.24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)14.46%
EPS NY rev (1m)0%
EPS NY rev (3m)9.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.46%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-1.63%
Valuation
Industry RankSector Rank
PE 11.58
Fwd PE 9.93
P/S 0.81
P/FCF 6.14
P/OCF 5.98
P/B 2.42
P/tB 2.86
EV/EBITDA 9.13
EPS(TTM)16.47
EY8.64%
EPS(NY)19.22
Fwd EY10.08%
FCF(TTM)31.04
FCFY16.28%
OCF(TTM)31.91
OCFY16.73%
SpS235.77
BVpS78.84
TBVpS66.73
PEG (NY)0.01
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.61%
ROE 19.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 9.01%
PM (TTM) 6.58%
GM N/A
FCFM 13.17%
ROA(3y)-0.09%
ROA(5y)1.6%
ROE(3y)-1.33%
ROE(5y)6.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-73.97%
OM growth 5Y-45.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 0.98
Debt/EBITDA 1.31
Cap/Depr 40.6%
Cap/Sales 0.37%
Interest Coverage 250
Cash Conversion 136.46%
Profit Quality 199.95%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC8.47%
ROIC/WACCN/A
Cap/Depr(3y)39.76%
Cap/Depr(5y)46.22%
Cap/Sales(3y)0.66%
Cap/Sales(5y)0.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)362.68%
EPS 3Y-60.54%
EPS 5Y-35.31%
EPS Q2Q%382.72%
EPS Next Y1713.23%
EPS Next 2Y359.52%
EPS Next 3Y185.3%
EPS Next 5Y94.56%
Revenue 1Y (TTM)11.67%
Revenue growth 3Y10.86%
Revenue growth 5Y7.47%
Sales Q2Q%10.55%
Revenue Next Year9.74%
Revenue Next 2Y8.62%
Revenue Next 3Y8.51%
Revenue Next 5Y5.99%
EBIT growth 1Y371.17%
EBIT growth 3Y-71.14%
EBIT growth 5Y-41.95%
EBIT Next Year2702.07%
EBIT Next 3Y235.71%
EBIT Next 5YN/A
FCF growth 1Y78.27%
FCF growth 3Y-8.57%
FCF growth 5Y-4.16%
OCF growth 1Y68.28%
OCF growth 3Y-8.34%
OCF growth 5Y-3.96%